Abstract
Although histaminergic neurones have not yet been histochemically visualized, there is little doubt that histamine (HA) has a neurotransmitter role in the invertebrate and mammalian central nervous system1,2. For example, a combination of biochemical, electrophysiological and lesion studies in rats have shown that histamine is synthesized in and released from a discrete set of neurones ascending through the lateral hypothalamic area and widely projecting in the telencephalon3–5. Histamine acts on target cells in mammalian brain via stimulation of two classes of receptor (H1 and H2) previously characterized in peripheral organs6,7 and probably uses Ca2+ and cyclic AMP, respectively, as second messengers8–10. It is well established that several neurotransmitters affect neuronal activity in the central nervous system through stimulation not only of postsynaptic receptors, but also of receptors located presynaptically which often display distinct pharmacological specificity and by which they may control their own release. Such ‘autoreceptors’ have been demonstrated (or postulated) in the case of noradrenaline, dopamine, serotonin, acetylcholine and γ-aminobutyric acid (GABA) neurones11,12 but have never been demonstrated for histamine. We show here that histamine inhibits its own release from depolarized slices of rat cerebral cortex, an action apparently mediated by a class of receptor (H3) pharmacologically distinct from those previously characterized, that is, the H1 and H2 receptors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Weinreich, D. in Biochemistry of Characterised Neurons (ed. Osborne, C. N. N.) 153–175 (Pergamon, Oxford, 1977).
Schwartz, J. C., Pollard, H. & Quach, T. T. J. Neurochem. 35, 26–33 (1980).
Garbarg, M., Barbin, G., Feger, J. & Schwartz, J. C. Science 186, 833–835 (1974).
Barbin, G., Garbarg, M., Schwartz, J. C. & Storm-Mathisen, J. J. Neurochem. 26, 259–263 (1976).
Haas, H. L. & Wolf, P. Pflügers Arch. ges. Physiol. 362, 38 (1976).
Ash, A. S. F. & Schild, H. O. Br. J. Pharmac. Chemother. 27, 427–439 (1966).
Black, J. W., Duncan, W. A. M., Durant, C. J., Ganellin, C. R. & Parsons, M. E. Nature 236, 385–390 (1972).
Quach, T. T., Duchemin, A. M., Rose, C. & Schwartz, J. C. Molec. Pharmac. 17, 301–308 (1980).
Palacios, J. M., Garbarg, M., Barbin, G. & Schwartz, J. C. Molec. Pharmac. 14, 971–982 (1978).
Hegstrand, L. R., Kanof, P. D. & Greengard, P. Nature 260, 163–165 (1976).
Langer, S. Z. Br. J. Pharmac. 60, 481–498 (1977).
Starke, K. A. Rev. Pharmac. Tox. 21, 7–30 (1981).
Baudry, M., Martres, M. P. & Schwartz, J. C. J. Neurochem. 21, 1301–1309 (1973).
Garbarg, M., Barbin, G., Bischoff, S., Pollard, H. & Schwartz, J. C. Brain Res. 106, 333–348 (1976).
Barbin, G., Hirsch, J.-C., Garbarg, M. & Schwartz, J. C. Brain Res. 92, 170–174 (1975).
Verdière, M., Rose, C. & Schwartz, J. C. Eur. J. Pharmac. 34, 157–168 (1975).
Tuomisto, L., Tuomisto, J. & Walaszek, E. J. Med. Biol. 53, 40–46 (1975).
Subramanian, N. & Mulder, A. H. Eur. J. Pharmac. 35, 203–206 (1976).
Biggs, M. J. & Johnson, E. S. Br. J. Pharmac. 70, 555–560 (1980).
Subramanian, N. Life Sci. 31, 557–562 (1982).
Taylor, K. M. & Snyder, S. H. J. Neurochem. 21, 1215–1223 (1973).
Schwartz, J. C., Lampart, C. & Rose, C. J. Neurochem. 19, 801–810 (1972).
Schwartz, J. C., Lampart, C. & Rose, C. J. Neurochem. 17, 1527–1534 (1970).
Durant, G. J. et al. Nature 276, 403–405 (1978).
Cheng, Y. C. & Prusoff, W. H. Biochem. Pharmac. 22, 3099–3108 (1973).
Ganellin, C. R. in Pharmacology of Histamine Receptors (eds Ganellin, C. R. & Parsons, M. E.) 10–102 (Wright PSG, Bristol, 1982).
Schwartz, J. C. et al. in Pharmacology of Histamine Receptors (eds Ganellin, C. R. & Parsons, M. E.) 351–391 (Wright PSG, Bristol, 1982).
Yellin, T. O., Buck, S. H., Gilman, D. J., Jones, D. F. & Wardleworth, J. M. Life Sci. 25, 2001–2009 (1979).
Parsons, M. E., Blakemore, R. C., Durant, G. J., Ganellin, C. R. & Rasmussen, A. C. Ag. Actions 5, 464 (1975).
Trung Tuong, M. D., Garbarg, M. & Schwartz, J. C. Nature 287, 548–551 (1980).
Black, J. W., Gerskowitch, V. P. & Leff, P. in Pharmacology of Histamine Receptors (eds Ganellin, C. R. & Parsons, M. E.) 1–9 (Wright PSG, Bristol, 1982).
Dismukes, K., Rogers, M. & Daly, J. W. J. Neurochem. 26, 785–790 (1976).
Werner, J., Van Der Lugt, J.-C., De Langen, C. D. J. & Mulder, A. H. J. Pharmac. exp. Ther. 211, 445–451 (1979).
Dolphin, A., Adrien, J., Hamon, M. & Bockaert, J. Molec. Pharmac. 15, 1–15 (1979).
Mounsey, I., Brady, K. A., Carroll, J., Fisher, R. & Middlemiss, D. N. Biochem. Pharmac. 31, 49–53 (1982).
Quach, T. T., Rose, C., Duchemin, A. M. & Schwartz, J. C. Nature 298, 373–375 (1982).
Snyder, S. H., Baldessarini, R. J. & Axelrod, J. J. Pharmac. exp. Ther. 153, 544–549 (1966).
Parker, R. B. & Waud, D. R. J. Pharmac. exp. Ther. 177, 1–12 (1971).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arrang, JM., Garbarg, M. & Schwartz, JC. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302, 832–837 (1983). https://doi.org/10.1038/302832a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/302832a0
This article is cited by
-
Structural insights into the agonists binding and receptor selectivity of human histamine H4 receptor
Nature Communications (2023)
-
Recovery of the histamine H3 receptor activity lost in yeast cells through error-prone PCR and in vivo selection
Scientific Reports (2023)
-
Anti-inflammatory effects of new human histamine H3 receptor ligands with flavonoid structure on BV-2 neuroinflammation
Inflammation Research (2023)
-
Structural basis for recognition of antihistamine drug by human histamine receptor
Nature Communications (2022)
-
The impact of pitolisant, an H3 receptor antagonist/inverse agonist, on perirhinal cortex activity in individual neuron and neuronal population levels
Scientific Reports (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.